156 related articles for article (PubMed ID: 24977153)
1. Biodistribution and SPECT imaging study of (99m)Tc labeling NGR peptide in nude mice bearing human HepG2 hepatoma.
Ma W; Wang Z; Yang W; Ma X; Kang F; Wang J
Biomed Res Int; 2014; 2014():618096. PubMed ID: 24977153
[TBL] [Abstract][Full Text] [Related]
2. (99m)Tc-labeled monomeric and dimeric NGR peptides for SPECT imaging of CD13 receptor in tumor-bearing mice.
Ma W; Kang F; Wang Z; Yang W; Li G; Ma X; Li G; Chen K; Zhang Y; Wang J
Amino Acids; 2013 May; 44(5):1337-45. PubMed ID: 23456486
[TBL] [Abstract][Full Text] [Related]
3. PET imaging of oncogene overexpression using 64Cu-vasoactive intestinal peptide (VIP) analog: comparison with 99mTc-VIP analog.
Thakur ML; Aruva MR; Gariepy J; Acton P; Rattan S; Prasad S; Wickstrom E; Alavi A
J Nucl Med; 2004 Aug; 45(8):1381-9. PubMed ID: 15299065
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and evaluation of novel Tc-99m labeled NGR-containing hexapeptides as tumor imaging agents.
Kim DW; Kim WH; Kim MH; Kim CG
J Labelled Comp Radiopharm; 2015 Feb; 58(2):30-5. PubMed ID: 25583160
[TBL] [Abstract][Full Text] [Related]
5. Biodistribution characteristics and SPECT imaging of (99m)Tc-RET and (99m)Tc-REG in human lung cancer xenografts.
Xie WH; Zhang B; Wang LH; Liu CY; Chang C; Lei B; Wu YW
Cancer Biother Radiopharm; 2015 Apr; 30(3):117-24. PubMed ID: 25714734
[TBL] [Abstract][Full Text] [Related]
6. Favorable biokinetic and tumor-targeting properties of 99mTc-labeled glucosamino RGD and effect of paclitaxel therapy.
Jung KH; Lee KH; Paik JY; Ko BH; Bae JS; Lee BC; Sung HJ; Kim DH; Choe YS; Chi DY
J Nucl Med; 2006 Dec; 47(12):2000-7. PubMed ID: 17138743
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of a New
Farahani AM; Maleki F; Sadeghzadeh N; Abediankenari S; Abedi SM; Erfani M
Anticancer Agents Med Chem; 2020; 20(14):1695-1703. PubMed ID: 32560611
[TBL] [Abstract][Full Text] [Related]
8. Preparation and comparative evaluation of
Vats K; Satpati D; Sharma R; Kumar C; Sarma HD; Banerjee S
J Labelled Comp Radiopharm; 2018 Feb; 61(2):68-76. PubMed ID: 29139598
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors.
Okarvi SM; Al Jammaz I
Nucl Med Biol; 2010 Apr; 37(3):277-88. PubMed ID: 20346867
[TBL] [Abstract][Full Text] [Related]
10. Preparation and characterization of 99mTc(CO)3-BPy-RGD complex as alphav beta3 integrin receptor-targeted imaging agent.
Zhang X; Chen X
Appl Radiat Isot; 2007 Jan; 65(1):70-8. PubMed ID: 17011200
[TBL] [Abstract][Full Text] [Related]
11. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
12. SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate.
Müller C; Forrer F; Schibli R; Krenning EP; de Jong M
J Nucl Med; 2008 Feb; 49(2):310-7. PubMed ID: 18199624
[TBL] [Abstract][Full Text] [Related]
13. Investigations of (99m)Tc-labeled glucarate as a SPECT radiotracer for non-small cell lung cancer (NSCLC) and potential tumor uptake mechanism.
Meng L; Xiu Y; Li Y; Xu X; Li S; Li X; Pak KY; Shi H; Cheng D
Nucl Med Biol; 2015 Jul; 42(7):608-13. PubMed ID: 25890861
[TBL] [Abstract][Full Text] [Related]
14. MicroSPECT/CT Imaging of Cell-Line and Patient-Derived EGFR-Positive Tumor Xenografts in Mice with Panitumumab Fab Modified with Hexahistidine Peptides To Enable Labeling with
Ku A; Chan C; Aghevlian S; Cai Z; Cescon D; Bratman SV; Ailles L; Hedley DW; Reilly RM
Mol Pharm; 2019 Aug; 16(8):3559-3568. PubMed ID: 31242384
[TBL] [Abstract][Full Text] [Related]
15. [Comparison of the biodistribution of four contrast agents in nude mice bearing NCI-H358 human lung cancer and evaluation of their value in diagnostic imaging].
Zhang JY; Feng J; Li HM; Li XD; Jia HL
Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):504-7. PubMed ID: 22093626
[TBL] [Abstract][Full Text] [Related]
16. The Distribution and Imaging of
Fan G; Wan R; Zhang B; Deng S; Peng M; Xue W; Xu L; Qin X; Wu Y
Cancer Biother Radiopharm; 2018 Dec; 33(10):445-459. PubMed ID: 30133308
[No Abstract] [Full Text] [Related]
17. Development of a SPECT Tracer to Image c-Met Expression in a Xenograft Model of Non-Small Cell Lung Cancer.
Han Z; Xiao Y; Wang K; Yan J; Xiao Z; Fang F; Jin Z; Liu Y; Sun X; Shen B
J Nucl Med; 2018 Nov; 59(11):1686-1691. PubMed ID: 29777004
[TBL] [Abstract][Full Text] [Related]
18. Imaging integrin alpha-v-beta-3 expression in tumors with an 18F-labeled dimeric RGD peptide.
Dijkgraaf I; Terry SY; McBride WJ; Goldenberg DM; Laverman P; Franssen GM; Oyen WJ; Boerman OC
Contrast Media Mol Imaging; 2013; 8(3):238-45. PubMed ID: 23606427
[TBL] [Abstract][Full Text] [Related]
19. A novel 99mTc-labeled molecular probe for tumor angiogenesis imaging in hepatoma xenografts model: a pilot study.
Zhao Q; Yan P; Wang RF; Zhang CL; Li L; Yin L
PLoS One; 2013; 8(4):e61043. PubMed ID: 23573294
[TBL] [Abstract][Full Text] [Related]
20. Comparison of in vitro and in vivo properties of [99mTc]cRGD peptides labeled using different novel Tc-cores.
Decristoforo C; Santos I; Pietzsch HJ; Kuenstler JU; Duatti A; Smith CJ; Rey A; Alberto R; Von Guggenberg E; Haubner R
Q J Nucl Med Mol Imaging; 2007 Mar; 51(1):33-41. PubMed ID: 17372571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
